These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9321527)

  • 1. Application of a first-pass effect model to characterize the pharmacokinetic disposition of venlafaxine after oral administration to human subjects.
    Taft DR; Iyer GR; Behar L; DiGregorio RV
    Drug Metab Dispos; 1997 Oct; 25(10):1215-8. PubMed ID: 9321527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes--focus on venlafaxine and O-desmethylvenlafaxine.
    Kandasamy M; Srinivas P; Subramaniam K; Ravi S; John J; Shekar R; Srinivas N; Thangam S
    Eur J Clin Pharmacol; 2010 Sep; 66(9):879-87. PubMed ID: 20446083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of venlafaxine, O-desmethylvenlafaxine, and O-desmethylvenlafaxine to venlafaxine ratio in postmortem human brain tissue.
    Murrell MD; Cruz DA; Javors MA; Thompson PM
    J Forensic Sci; 2014 May; 59(3):683-9. PubMed ID: 24502274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age and gender on venlafaxine and O-desmethylvenlafaxine pharmacokinetics.
    Klamerus KJ; Parker VD; Rudolph RL; Derivan AT; Chiang ST
    Pharmacotherapy; 1996; 16(5):915-23. PubMed ID: 8888087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.
    Lessard E; Yessine MA; Hamelin BA; O'Hara G; LeBlanc J; Turgeon J
    Pharmacogenetics; 1999 Aug; 9(4):435-43. PubMed ID: 10780263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithium.
    Troy SM; Parker VD; Hicks DR; Boudino FD; Chiang ST
    J Clin Pharmacol; 1996 Feb; 36(2):175-81. PubMed ID: 8852394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine metabolism as a marker of cytochrome P450 enzyme 2D6 metabolizer status.
    Nichols AI; Lobello K; Guico-Pabia CJ; Paul J; Preskorn SH
    J Clin Psychopharmacol; 2009 Aug; 29(4):383-6. PubMed ID: 19593180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine Does Not Alter the Pharmacokinetics of Venlafaxine Enantiomers in Healthy Subjects Phenotyped for CYP2D6, CYP2C19, and CYP3A.
    Tozatto E; Benzi JRL; Rocha A; Coelho EB; Lanchote VL
    J Clin Pharmacol; 2021 Mar; 61(3):319-327. PubMed ID: 32974907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects.
    Lindauer A; Siepmann T; Oertel R; Jung A; Ziemssen T; Jaehde U; Kirch W; Siepmann M
    Clin Pharmacokinet; 2008; 47(11):721-31. PubMed ID: 18840027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Zuojin Pill on the Metabolism of Venlafaxine in Vitro and in Rats and Associated Herb-Drug Interaction.
    Li Y; Li J; Yan D; Wang Q; Jin J; Tan B; Qiu F
    Drug Metab Dispos; 2020 Oct; 48(10):1044-1052. PubMed ID: 32561594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism.
    Paulzen M; Haen E; Hiemke C; Fay B; Unholzer S; Gründer G; Schoretsanitis G
    J Affect Disord; 2018 Feb; 227():506-511. PubMed ID: 29156365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series.
    Paslakis G; Gilles M; Deuschle M
    J Clin Psychopharmacol; 2010 Aug; 30(4):473-4. PubMed ID: 20631572
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine.
    Lindh JD; Annas A; Meurling L; Dahl ML; AL-Shurbaji A
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):401-6. PubMed ID: 12898080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of venlafaxine extended release 75  mg and desvenlafaxine 50  mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study.
    Nichols AI; Focht K; Jiang Q; Preskorn SH; Kane CP
    Clin Drug Investig; 2011; 31(3):155-67. PubMed ID: 21288052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine: a heterocyclic antidepressant.
    Ellingrod VL; Perry PJ
    Am J Hosp Pharm; 1994 Dec; 51(24):3033-46. PubMed ID: 7856622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects.
    Ciusani E; Zullino DF; Eap CB; Brawand-Amey M; Brocard M; Baumann P
    J Psychopharmacol; 2004 Dec; 18(4):559-66. PubMed ID: 15582923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
    Pandey A; Price A; Ayala-Lopez N; Garza KY; Marzinke MA; Knezevic CE
    J Pharm Biomed Anal; 2024 Jun; 243():116082. PubMed ID: 38461636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants.
    Ilett KF; Kristensen JH; Hackett LP; Paech M; Kohan R; Rampono J
    Br J Clin Pharmacol; 2002 Jan; 53(1):17-22. PubMed ID: 11849190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.
    Kennedy SH; McCann SM; Masellis M; McIntyre RS; Raskin J; McKay G; Baker GB
    J Clin Psychiatry; 2002 Mar; 63(3):181-6. PubMed ID: 11926715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarification of venlafaxine chemistry, pharmacology, and pharmacokinetics.
    Albano D; Amchin J
    Am J Health Syst Pharm; 1995 Jul; 52(14):1573-4. PubMed ID: 7552908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.